Latest research on Eprex

Human erythropoietin (recombinant), produced by CHO cells.

Eprex dosage

Although the dose of Eprex (erythropoietin) did not change during the study, the level of hemoglobin was increased after active and passive intradialytic exercise programs. [source, 2015]
The fat mass was seeded on dishes in appropriate culture on average for 24 hours and then treated for 3 weeks with 3 different doses of EPO (Eprex, Janssen-Cilag, Milan, Italy): 0.15, 0.30, and 0.60 μg/ml. [source, 2015]
Recombinant human EPO (Procrit from Amgen) was given in three consecutive doses at 3,000 IU on day 1, 1,000 IU on day 2, and day 3. [source, 2014]
After the inducement of pancreatitis, a dosage of 1000 U/kg/day (5 IU) of intraperitoneal EPO (Eprex, 2000 U/0.5 mL from Gürel İlaç Ticaret, İstanbul) was administered for three days to the EPO Group. [source, 2014]
To provide an erythropoietic stimulus, mice were phlebotomized by retro-orbital puncture (500 μL) or treated with a single dose of 200 units human erythropoietin (Epogen, Amgen), and analyzed within 24–48 hours. [source, 2014]
rHuEPO was given at a 150 IU/kg/dose, 3 times a week, subcutaneously (rHuEPO made by Cilag Inc (Zug, Switzerland) and marketed as Eprex) in 60 patients. [source, 2014]
Seventy-seven patients received an individual ESA dosage (Aranesp, Eprex, Neorecormon or Mircera) with the aim of maintaining the haemoglobin level between 100 and 120 g/L. [source, 2014]
Phase III trial data also suggest that for patients requiring very high Epogen doses at baseline, perhaps due to antibody-mediated interactions, they required significantly less dose of peginesatide to achieve comparable hemoglobin. [source, 2013]
If administered at the recommended dose of 0.04 mg/kg monthly, Omontys is estimated to cost approximately $302 wholesale, which is significantly less than a comparable dose of Aranesp (darbepoetin alfa) administered weekly or Procrit (Jannsen Pharmaceuticals, Inc., Tutisville, NJ, USA) (epoetin alfa) three times weekly, both of which are estimated to cost around slightly more than $700 monthly. [source, 2013]
Prior to the use of Epogen to treat anemia in patients on long-term dialysis, the majority of patients receiving Captopril developed dose dependent anemia that was reversed upon discontinuation of Captopril treatment (4). [source, 2013]